Exclusive: Germany’s Merck KGaA Negotiating Acquisition of US Cancer Biotech Firm Springworks, Sources Reveal

Exclusive-Germany's Merck KGaA in talks to buy US cancer biotech firm Springworks, sources say

Merck KGaA’s Potential Acquisition of Springworks Therapeutics: A Shift in the Pharma Landscape In the ever-evolving landscape of the pharmaceutical industry, big moves are often on the horizon. Recent reports indicate that Merck KGaA, the … Read more